I wish these addressed risk from conventional immunosuppression used in transplant (Thymo, calcineurin inhibitors TAC/CSA, antimetabolites MMF/AZA). Particularly in kidney transplant, we occasionally see HBVr in HBcAb+/sAg-, despite HBsAb+, but the practice of universal proph is not widely adopted.

We've started using it!

Candidates for LOIs. Then letter writers when a formal letter is required.

Pushing Back Against Race-Based Medicine - ASHP Pharmacists should challenge the use of patients' race in clinical decision-making tools, a still-routine practice shown to delay diagnosis and treatment for Black patients, two presenters said at a M...

Key points from a talk I co-presented at #ASHP2024 on removing race from clinical calculators - eGFR, KDPI, KTxp rejection risk assessment #pharmsky #txppharm news.ashp.org/News/Meeting...

LiverTox is a great reference to use here to evaluate patterns and timing of injury.

Discussed this recently at a formulary meeting. Based on a few studies ~17-20% of pts on TIW HD experience K >6.0. Those against adding due to high cost claimed it would encourage nonadherence to dietary restrictions... Or would it enable healthier dietary choices by alleviating restrictions??

Has one of the best brand names and icons too. Trojan horse.

The medsky labeler is my favorite one.

I will be giving two talks, one is an update on MASLD and is one on the impact of race in clinical calculations. I will also be at the residency showcase.

Please add me :)

Surgery too.
How about keeping Mg >/= 2.0 for the general population?

Add your pharmacy/medical discipline badges!